Skip to Main Content

Author Details

Lana Y H Lai
The University of Manchester, University of Manchester
2013
29
10
PMIDPaper TitleJournal TitlePublished Year
35012410Characteristics and outcomes of COVID-19 patients with and without asthma from the United States, South Korea, and Europe.J Asthma2023
37328600Serially Combining Epidemiological Designs Does Not Improve Overall Signal Detection in Vaccine Safety Surveillance.Drug Saf2023
36826399Reproducible variability: assessing investigator discordance across 9 research teams attempting to reproduce the same observational study.J Am Med Inform Assoc2023
35873596Vaccine Safety Surveillance Using Routinely Collected Healthcare Data-An Empirical Evaluation of Epidemiological Designs.Front Pharmacol2022
35345821Unraveling COVID-19: A Large-Scale Characterization of 4.5 Million COVID-19 Cases Using CHARYBDIS.Clin Epidemiol2022
35392566Current Approaches to Vaccine Safety Using Observational Data: A Rationale for the EUMAEUS (Evaluating Use of Methods for Adverse Events Under Surveillance-for Vaccines) Study Design.Front Pharmacol2022
36506524Corrigendum: Vaccine safety surveillance using routinely collected healthcare data-An empirical evaluation of epidemiological designs.Front Pharmacol2022
33269356Use of dialysis, tracheostomy, and extracorporeal membrane oxygenation among 842,928 patients hospitalized with COVID-19 in the United States.medRxiv2021
33725121COVID-19 in patients with autoimmune diseases: characteristics and outcomes in a multinational network of cohorts across three countries.Rheumatology (Oxford)2021
33688639Unraveling COVID-19: a large-scale characterization of 4.5 million COVID-19 cases using CHARYBDIS.Res Sq2021
34937726Characteristics and outcomes of patients with COVID-19 with and without prevalent hypertension: a multinational cohort study.BMJ Open2021
34899334Bias, Precision and Timeliness of Historical (Background) Rate Comparison Methods for Vaccine Safety Monitoring: An Empirical Multi-Database Analysis.Front Pharmacol2021
34272262Characteristics and Outcomes of Over 300,000 Patients with COVID-19 and History of Cancer in the United States and Spain.Cancer Epidemiol Biomarkers Prev2021
34267326Characteristics and outcomes of 627 044 COVID-19 patients living with and without obesity in the United States, Spain, and the United Kingdom.Int J Obes (Lond)2021
33975825Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort study.BMJ2021
34049958Thirty-Day Outcomes of Children and Adolescents With COVID-19: An International Experience.Pediatrics2021
33269355Characteristics, outcomes, and mortality amongst 133,589 patients with prevalent autoimmune diseases diagnosed with, and 48,418 hospitalised for COVID-19: a multinational distributed network cohort analysis.medRxiv2020
33140068Baseline phenotype and 30-day outcomes of people tested for COVID-19: an international network cohort including >3.32 million people tested with real-time PCR and >219,000 tested positive for SARS-CoV-2 in South Korea, Spain and the United States.medRxiv2020
31648282Variation in methods, results and reporting in electronic health record-based studies evaluating routine care in gout: A systematic review.PLoS One2019
29531778Association between glucocorticoid therapy and incidence of diabetes mellitus in polymyalgia rheumatica and giant cell arteritis: a systematic review and meta-analysis.RMD Open2018
29804057Evaluation of person-level heterogeneity of treatment effects in published multiperson N-of-1 studies: systematic review and reanalysis.BMJ Open2018
28365575A Patient-reported Outcome Measure for Effect of Glucocorticoid Therapy in Adults with Inflammatory Diseases Is Needed: Report from the OMERACT 2016 Special Interest Group.J Rheumatol2017
26908865Field Synopsis of Sex in Clinical Prediction Models for Cardiovascular Disease.Circ Cardiovasc Qual Outcomes2016
27151514Field Synopsis of the Role of Sex in Stroke Prediction Models.J Am Heart Assoc2016
25656378Lack of association of apolipoprotein E (Apo E) polymorphism with the prevalence of metabolic syndrome: the National Heart, Lung and Blood Institute Family Heart Study.Diabetes Metab Res Rev2015
26152680Clinical Prediction Models for Cardiovascular Disease: Tufts Predictive Analytics and Comparative Effectiveness Clinical Prediction Model Database.Circ Cardiovasc Qual Outcomes2015
24233388Bleeding events and associated factors in a cohort of adult patients taking warfarin in Sarawak, Malaysia.J Thromb Thrombolysis2014
23661171CYP2C19 genotypes and their impact on clopidogrel responsiveness in percutaneous coronary intervention.Int J Clin Pharm2013
24145261Trends of platelet inhibition in different clopidogrel pretreatment patterns in malaysian patients undergoing elective percutaneous coronary intervention.Med J Malaysia2013
  • 1 - 29 of 29

Recommended Authors

University of Oxford
Career Start Year 2018
Number of shared co-authors 34
Mayo Clinic
Career Start Year 2015
Number of shared co-authors 0
Center for Pediatric Clinical Effectiveness, The Children's Hospital of Philadelphia
Career Start Year 2014
Number of shared co-authors 0
Center for Clinical Investigation, Brigham and Women's Hospital
Career Start Year 2014
Number of shared co-authors 0
Janssen Pharmaceutical Research and Development
Career Start Year 2014
Number of shared co-authors 45
USA Tempus Labs Inc.
Career Start Year 2012
Number of shared co-authors 17
Harvard Medical School
Career Start Year 2011
Number of shared co-authors 4
Vanderbilt University Medical Center
Career Start Year 2011
Number of shared co-authors 0
Department of Health Services, Brown University School of Public Health
Career Start Year 2010
Number of shared co-authors 1
Brigham and Women's Hospital, Harvard Medical School
Career Start Year 2009
Number of shared co-authors 3
Cardiovascular Health Research Unit, University of Washington
Career Start Year 2008
Number of shared co-authors 0
National Institute of Diabetes and Digestive and Kidney Disease
Career Start Year 2007
Number of shared co-authors 1
VA Boston Healthcare System
Career Start Year 2007
Number of shared co-authors 3
Harvard Medical School and Harvard Pilgrim Health Care Institute
Career Start Year 2006
Number of shared co-authors 6
Brigham and Women's Hospital, Harvard Medical School
Career Start Year 2006
Number of shared co-authors 3
UT Southwestern Medical Center
Career Start Year 2006
Number of shared co-authors 1
Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital
Career Start Year 2005
Number of shared co-authors 4
Ralph H. Johnson Veterans Affairs Healthcare System.
Career Start Year 2004
Number of shared co-authors 0
Vanderbilt University Medical Center
Career Start Year 2004
Number of shared co-authors 1
Ben Gurion University
Career Start Year 2003
Number of shared co-authors 0
Vanderbilt University Medical Center
Career Start Year 2002
Number of shared co-authors 1
Pennsylvania State University-Milton S. Hershey Medical Center
Career Start Year 2001
Number of shared co-authors 0
University of California-San Francisco
Career Start Year 1998
Number of shared co-authors 2
David Geffen School of Medicine, University of California los angeles
Career Start Year 1998
Number of shared co-authors 2
Stanford University
Career Start Year 1997
Number of shared co-authors 1
Division of Pharmacoepidemiology, Brigham & Women's Hospital, Harvard Medical School
Career Start Year 1996
Number of shared co-authors 5
Stanford University
Career Start Year 1994
Number of shared co-authors 3
Columbia University.
Career Start Year 1990
Number of shared co-authors 17
University of North Carolina at Chapel Hill
Career Start Year 1988
Number of shared co-authors 3

Collaborators

University of California los angeles
Co-authored papers 17
Columbia University
Co-authored papers 17
Columbia University Irving Medical Center
Co-authored papers 16
Riyadh Elm University
Co-authored papers 16
University of Oxford
Co-authored papers 16
University of Gothenburg
Co-authored papers 16
Northeastern University
Co-authored papers 13
Erasmus University Medical Center
Co-authored papers 13
OHDSI Center at The Roux Institute, Northeastern University
Co-authored papers 12
University of Utah Health
Co-authored papers 12
University of Utah
Co-authored papers 12
Stanford University
Co-authored papers 12
American College of Medical Informatics, Department of Veteran Affairs, Harvard University T H Chan School of Public Health, Massachusetts Institute of Technology, The American Society for Clinical Investigation, University of Kentucky, Vanderbilt University Medical Center, Vanderbilt University Medical School
Co-authored papers 11
University of Oxford
Co-authored papers 11
University of Dundee
Co-authored papers 11
Erasmus University Medical Center
Co-authored papers 11
Universidad del Norte
Co-authored papers 11
Stanford University
Co-authored papers 10
Co-authored papers 10
Erasmus University Medical Center
Co-authored papers 10
O'Brien Institute for Public Health, University of Calgary
Co-authored papers 10
College of Engineering, University of Arizona
Co-authored papers 9
Yonsei University College of Medicine
Co-authored papers 9
University of Colorado Anschutz Medical Campus
Co-authored papers 8
Columbia University Irving Medical Center
Co-authored papers 7
Bayer Pharmaceuticals
Co-authored papers 7
Columbia University Irving Medical Center
Co-authored papers 7
University of Oxford
Co-authored papers 7
University of Oxford
Co-authored papers 7
NMC Royal Hospital
Co-authored papers 7